02.03.2010 • News

Eastman Sues DAK Americas

Eastman Chemical Company said it has filed a lawsuit against DAK Americas in connection with their unauthorized use of IntegRex PET technology. Eastman developed the technology for the production of PET and said it continues to protect this "technology with a robust patent portfolio." Eastman said it "will vigorously defend these intellectual property assets."

Eastman filed its complaint in the U.S. District Court for the District of Delaware. The complaint alleges patent infringement of three Eastman patents that represent a portion of Eastman's IntegRex technology patent portfolio.

Eastman previously filed a lawsuit against Indorama companies located in the U.S., Europe, and Thailand in connection with their unauthorized use of IntegRex PET technology.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

most read